Subscribe
marilyn-nieves
marilyn-nieves / iStockphoto.com
7 September 2017Americas

PhRMA and BIO take legal action against Nevada law

Two biotech associations have filed litigation in a district court challenging the provisions of a Nevada law, saying it violates patent rights.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
PhRMA reacts to FDA’s biosimilars guidance
15 August 2014   PhRMA has voiced concerns about the FDA’s draft guidance on biosimilars, which it suggests if enacted, could have an impact on the safety of biosimilar products.
Americas
PhRMA urges USTR to protect US innovation abroad
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Plant Varieties
Nevada judge overrules objections in patent disclosure suit
20 July 2021   A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024

More on this story

Americas
PhRMA reacts to FDA’s biosimilars guidance
15 August 2014   PhRMA has voiced concerns about the FDA’s draft guidance on biosimilars, which it suggests if enacted, could have an impact on the safety of biosimilar products.
Americas
PhRMA urges USTR to protect US innovation abroad
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Plant Varieties
Nevada judge overrules objections in patent disclosure suit
20 July 2021   A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.

More on this story

Americas
PhRMA reacts to FDA’s biosimilars guidance
15 August 2014   PhRMA has voiced concerns about the FDA’s draft guidance on biosimilars, which it suggests if enacted, could have an impact on the safety of biosimilar products.
Americas
PhRMA urges USTR to protect US innovation abroad
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Plant Varieties
Nevada judge overrules objections in patent disclosure suit
20 July 2021   A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.

More features

Gilead scores win in fake HIV drug dispute
Polsinelli grows roster with ex-corporate counsel
‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird
Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers